4.5 Article

Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships

期刊

JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 271, 期 1-2, 页码 53-60

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2008.03.009

关键词

brain; magnetic resonance imaging; microalbuminuria; vascular risk factors; diabetes; hypertension

资金

  1. NHLBI NIH HHS [U01 HL054464] Funding Source: Medline
  2. NINDS NIH HHS [R01 NS041558-01, R01 NS041558] Funding Source: Medline

向作者/读者索取更多资源

Background: Because of similarities between brain and kidney microvascular disease, there may be a relationship between measures of renal microvascular disease and brain structural changes in middle aged or elderly individuals. Objective: To determine whether the urine albumin/creatinine ratio (UACR), a measure of renal microvascular disease, is associated with brain atrophy and white matter hyperintensities. Methods: As part of a larger study of the genetics of hypertension, we performed brain imaging and assessed microalbuminuria and other vascular risk factors including diabetes, hypertension, hyperlipidemia and hyperhomocysteinemia in 1253 individuals from hypertensive sibships (age mean 63.8 years, range 50 to 91; 65% women; 49% African-American; 78% hypertensive). Semi-automated quantitative measurements of brain atrophy (BA) ventricular volume, and white matter hyperintensities (WMH) were carried out on the brain MR scans. Results: In logistic regression models, elevated UACR was associated with greater BA (odds ratio (OR)= 1.70 (95% CI 1.14, 2.54) and burden of WMH (OR=2.06 (95% CI 1.37, 3.10) after controlling for demographic factors, blood glucose, hypertension severity, duration of smoking and serum homocysteine. In contrast to elevated UACR, the associations with elevated creatinine or reduced glomerular filtration rate and WMH were not significant in the fully adjusted models. Conclusions: In this cohort with an overrepresentation of hypertensives, elevated UACR was independently associated with both brain atrophy and white matter hyperintensities. Brain volume loss and WMH burden might represent expressions of microvascular disease that share common mechanisms with nephrosclerosis. (C) 2008 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging

Janina Krell-Roesch, Martin Rakusa, Jeremy A. Syrjanen, Argonde C. van Harten, Val J. Lowe, Clifford R. Jack, Walter K. Kremers, David S. Knopman, Gorazd B. Stokin, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda

Summary: This study examined the association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms in older non-demented adults. The results showed that lower CSF Aβ42 and higher t-tau/Aβ42 and p-tau/Aβ42 ratios were associated with depression, anxiety, and other NPS.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Biomarker clustering in autosomal dominant Alzheimer's disease

Patrick H. Luckett, Charlie Chen, Brian A. Gordon, Julie Wisch, Sarah B. Berman, Jasmeer P. Chhatwal, Carlos Cruchaga, Anne M. Fagan, Martin R. Farlow, Nick C. Fox, Mathias Jucker, Johannes Levin, Colin L. Masters, Hiroshi Mori, James M. Noble, Stephen Salloway, Peter R. Schofield, Adam M. Brickman, William S. Brooks, David M. Cash, Michael J. Fulham, Bernardino Ghetti, Clifford R. Jack, Jonathan Voeglein, William E. Klunk, Robert Koeppe, Yi Su, Michael Weiner, Qing Wang, Daniel Marcus, Deborah Koudelis, Nelly Joseph-Mathurin, Lisa Cash, Russ Hornbeck, Chengjie Xiong, Richard J. Perrin, Celeste M. Karch, Jason Hassenstab, Eric McDade, John C. Morris, Tammie L. S. Benzinger, Randall J. Bateman, Beau M. Ances

Summary: This study analyzed 19 biomarkers of Alzheimer's disease using hierarchical clustering and feature selection, and found that amyloid and tau measures were the primary predictors. Emerging biomarkers of neuronal integrity and inflammation showed weaker predictive ability.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

APOE ε4 influences medial temporalatrophy and tau deposition in atypical Alzheimer's disease

Neha Atulkumar Singh, Nirubol Tosakulwong, Jonathan Graff-Radford, Mary M. Machulda, Nha Trang Thu Pham, Irene Sintini, Stephen D. Weigand, Christopher G. Schwarz, Matthew L. Senjem, Minerva M. Carrasquillo, Nilufer Ertekin-Taner, Clifford R. Jack, Val J. Lowe, Keith A. Josephs, Jennifer L. Whitwell

Summary: APOE epsilon 4 is an important genetic risk factor for typical Alzheimer's disease (AD), but its influence in atypical presentations of AD is not well-known. This study found that APOE epsilon 4 carriers had smaller hippocampal and amygdala volumes and greater tau deposition, while non-carriers showed faster rates of atrophy and tau accumulation in certain brain regions.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Association of neighborhood socioeconomic disadvantage and cognitive impairment

Maria Vassilaki, Jeremiah A. Aakre, Anna Castillo, Alanna M. Chamberlain, Patrick M. Wilson, Walter K. Kremers, Michelle M. Mielke, Yonas E. Geda, Mary M. Machulda, Rabe E. Alhurani, Jonathan Graff-Radford, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack, David S. Knopman, Ronald C. Petersen

Summary: The study found an association between neighborhood socioeconomic deprivation and cognitive decline, mild cognitive impairment, and dementia in older adults. Higher levels of neighborhood deprivation were associated with an increased risk of progression to dementia and slightly faster cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers

Michael W. Weiner, Danielle Harvey, Susan M. Landau, Dallas P. Veitch, Thomas C. Neylan, Jordan H. Grafman, Paul S. Aisen, Ronald C. Petersen, Clifford R. Jack, Duygu Tosun, Leslie M. Shaw, John Q. Trojanowski, Andrew J. Saykin, Jacqueline Hayes, Charles De Carli

Summary: The study found no significant association between TBI and/or PTSD and biomarker-defined AD. Veterans with TBI and/or PTSD had poorer cognitive status, which may be attributed to other comorbid pathologies.

ALZHEIMERS & DEMENTIA (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus

Emanuele Camerucci, Jonathan Graff-Radford, David T. Jones, Benjamin D. Elder, Jeffrey L. Gunter, Jeremy K. Cutsforth-Gregory, Hugo Botha, Matthew C. Murphy, Derek R. Johnson, Caroline Davidge-Pitts, Clifford R. Jack, John Huston, Petrice M. Cogswell

Summary: This study evaluated the change in size of focally enlarged sulci (FES) and pituitary height after shunt placement in patients with idiopathic normal pressure hydrocephalus (iNPH). The results showed a significant decrease in FES volume and a significant increase in pituitary gland size after shunt placement.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Oncology

Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration

Firat Kara, Christine M. Lohse, Anna M. Castillo, Nirubol Tosakulwong, Timothy G. Lesnick, Clifford R. Jack, Ronald C. Petersen, Janet E. Olson, Fergus J. Couch, Kathryn J. Ruddy, Kejal Kantarci, Michelle M. Mielke

Summary: This study aimed to investigate whether the use of selective estrogen receptor modifiers (SERMs), including tamoxifen and raloxifene, was associated with cognitive performance and markers of neurodegeneration associated with Alzheimer's disease. The results showed no significant associations between the use of SERMs and cognition or MCI in both breast cancer patients and women without a history of cancer.

CANCER MEDICINE (2023)

Article Clinical Neurology

Predicting amyloid PET and tau PET stages with plasma biomarkers

Clifford R. Jack Jr, Heather J. Wiste, Alicia Algeciras-Schimnich, Dan J. Figdore, Christopher G. Schwarz, Val J. Lowe, Vijay K. Ramanan, Prashanthi Vemuri, Michelle M. Mielke, David S. Knopman, Jonathan Graff-Radford, Bradley F. Boeve, Kejal Kantarci, Petrice M. Cogswell, Matthew L. Senjem, Jeffrey L. Gunter, Terry M. Therneau, Ronald C. Petersen

Summary: Staging the severity of Alzheimer's disease pathology is important for therapeutic trials and clinical prognosis. Biomarkers such as amyloid and tau PET can be used for disease staging, but plasma biomarkers would be more practical.
Article Clinical Neurology

Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis

Vijay K. Ramanan, Robel K. Gebre, Jonathan Graff-Radford, Ekaterina Hofrenning, Alicia Algeciras-Schimnich, Daniel J. Figdore, Val J. Lowe, Michelle M. Mielke, David S. Knopman, Owen A. Ross, Clifford R. Jack Jr, Ronald C. Petersen, Prashanthi Vemuri

Summary: Ramanan et al. found that integrating genetic risk scores improves the diagnostic value of plasma biomarkers for Alzheimer's disease, especially in predicting amyloid PET positivity. However, more advances are needed before these biomarkers can be widely used. By analyzing a large sample, they discovered that the AD-GRS is independently associated with amyloid PET levels and significantly enhances the classification accuracy of amyloid PET positivity when combined with high plasma p-tau(181). Machine learning methods that incorporate plasma biomarkers, demographics, and the AD-GRS show high accuracy in predicting amyloid PET levels.
Article Clinical Neurology

Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea

Diego Z. Carvalho, Stuart J. McCarter, Erik K. St Louis, Scott A. Przybelski, Kohl Johnson L. Sparrman, Virend K. Somers, Bradley F. Boeve, Ronald C. Petersen, Clifford R. Jack Jr, Jonathan Graff-Radford, Prashanthi Vemuri

Summary: This study aimed to investigate the association between polysomnographic (PSG) sleep parameters and neuroimaging biomarkers of cerebrovascular disease (CVD) in older adults with obstructive sleep apnea (OSA). The results showed that reduced slow-wave sleep and severe OSA were associated with increased burden of white matter abnormalities in older adults, which may contribute to a higher risk of cognitive impairment, dementia, and stroke.

NEUROLOGY (2023)

Article Clinical Neurology

Altered within- and between-network functional connectivity in atypical Alzheimer's disease

Neha Atulkumar Singh, Peter R. Martin, Jonathan Graff-Radford, Irene Sintini, Mary M. Machulda, Joseph R. Duffy, Jeffrey L. Gunter, Hugo Botha, David T. Jones, Val J. Lowe, Clifford R. JackJr, Keith A. Josephs, Jennifer L. Whitwell

Summary: Posterior cortical atrophy and logopenic progressive aphasia are atypical clinical presentations of Alzheimer's disease, both showing disruptions in functional networks. The language network is affected in logopenic progressive aphasia, while the visual network is affected in posterior cortical atrophy. However, there is limited knowledge about the differences in connectivity within and between brain networks in these atypical Alzheimer's disease phenotypes.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease

Nick Corriveau-Lecavalier, Jeffrey L. Gunter, Michael Kamykowski, Ellen Dicks, Hugo Botha, Walter K. Kremers, Jonathan Graff-Radford, Daniela A. Wiepert, Christopher G. Schwarz, Essa Yacoub, David S. Knopman, Bradley F. Boeve, Kamil Ugurbil, Ronald C. Petersen, Clifford R. Jack, Melissa J. Terpstra, David T. Jones

Summary: From a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating functional operations underpinning cognitive phenomena. Age-related disruption of the default mode network is accelerated by amyloid deposition in all syndromic presentations of Alzheimer's disease, while syndromic variability may reflect selective neurodegeneration of modular networks supporting specific cognitive abilities. This study investigates the use of a biomarker of default mode network dysfunction, the network failure quotient, to assess Alzheimer's disease in a normative cohort and differentiate between different phenotypes of the disease. The study provides important insights into the shared pathophysiological mechanisms and distinct neurodegenerative processes involved in Alzheimer's disease.

BRAIN COMMUNICATIONS (2023)

Article Neurosciences

Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)

Nicole S. McKay, Brian A. Gordon, Russ C. Hornbeck, Aylin Dincer, Shaney Flores, Sarah J. Keefe, Nelly Joseph-Mathurin, Clifford R. Jack, Robert Koeppe, Peter R. Millar, Beau M. Ances, Charles D. Chen, Alisha Daniels, Diana A. Hobbs, Kelley Jackson, Deborah Koudelis, Parinaz Massoumzadeh, Austin McCullough, Michael L. Nickels, Farzaneh Rahmani, Laura Swisher, Qing Wang, Ricardo F. Allegri, Sarah B. Berman, Adam M. Brickman, William S. Brooks, David M. Cash, Jasmeer P. Chhatwal, Gregory S. Day, Martin R. Farlow, Christian la Fougere, Nick C. Fox, Michael Fulham, Bernardino Ghetti, Neill Graff-Radford, Takeshi Ikeuchi, William Klunk, Jae-Hong Lee, Johannes Levin, Ralph Martins, Colin L. Masters, Jonathan McConathy, Hiroshi Mori, James Noble, Gerald Reischl, Christopher Rowe, Stephen Salloway, Raquel Sanchez-Valle, Peter R. Schofield, Hiroyuki Shimada, Mikio Shoji, Yi Su, Kazushi Suzuki, Jonathan Voeglein, Igor Yakushev, Carlos Cruchaga, Jason Hassenstab, Celeste Karch, Eric McDade, Richard J. Perrin, Chengjie Xiong, John C. Morris, Randall J. Bateman, Tammie L. S. Benzinger

Summary: The Dominantly Inherited Alzheimer Network (DIAN) is an international collaboration that studies autosomal dominant Alzheimer disease (ADAD). ADAD arises from mutations in three genes. Non-carrier siblings from ADAD families can be recruited for case-control studies. The predictable age of onset in ADAD allows for mapping candidate AD biomarkers during the preclinical phase. This study provides valuable data for understanding early disease stages of both ADAD and sporadic AD, as well as for research in healthy aging.

NATURE NEUROSCIENCE (2023)

Article Clinical Neurology

Association of Olfaction and Microstructural Integrity of Brain Tissue in Community-Dwelling Adults

Srishti Shrestha, Xiaoqian Zhu, Kevin J. Sullivan, Chad Blackshear, Jennifer A. Deal, A. Richey Sharrett, Vidyulata Kamath, Andrea L. C. Schneider, Clifford R. Jack, Juebin Huang, Priya Palta, Robert I. Reid, David S. Knopman, Rebecca F. Gottesman, Honglei Chen, B. Gwen Windham, Michael E. Griswold, Jr Thomas H. Mosley

Summary: Research shows that neuronal microstructural integrity in multiple brain regions, particularly the medial temporal lobe (MTL), is associated with odor identification ability. The associations between microstructural integrity and olfaction are stronger in individuals with mild cognitive impairment (MCI) compared to those with normal cognition, suggesting different effects of dementia pathogenesis.

NEUROLOGY (2023)

Article Clinical Neurology

Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume The ARIC Study

Keenan A. Walker, Ron C. Hoogeveen, Aaron R. Folsom, Christie M. Ballantyne, David S. Knopman, B. Gwen Windham, Clifford R. Jack Jr, Rebecca F. Gottesman

Summary: In the article "Midlife Systemic Inflammatory Markers Are Associated With Late-Life Brain Volume: The ARIC Study" by Walker et al., coding errors were found to have affected the statistical analyses. The authors have corrected the errors and reanalyzed the data, stating that the errors did not change the overall message of the article. The identified errors include misclassification of a nominal covariate, use of incorrect alcohol use covariate, and an error in the scaling of beta coefficients.

NEUROLOGY (2023)

暂无数据